Impact of migration on diabetes burden: audit in the metropolitan area of Bologna, Italy

J Endocrinol Invest. 2024 Feb;47(2):411-420. doi: 10.1007/s40618-023-02157-6. Epub 2023 Jul 20.

Abstract

Purpose: To investigate the impact of diabetes in immigrants on the Italian healthcare system, as well as their compliance with standard protocols of control and treatment.

Methods: The prevalence of immigrants with diabetes living in the metropolitan area of Bologna (about 1 million inhabitants) in 2019 was investigated using a database containing all subjects in active follow-up for diabetes, based on antidiabetic drug use, disease-specific copayment exemption, ICD-9 codes, continuous care in diabetes units. Country of origin was derived from fiscal code.

Results: The overall prevalence of diabetes (n = 53,941; 51.8% males, median age 64) was 6.1% in both Italy-born and immigrant cohorts. Immigrant prevalence was 12.4%, moderately higher than that observed in the total population (12.2%). Diabetes risk was increased in the whole immigrant cohort (odds ratio (OR) 1.74; 95% Confidence Interval (CI) 1.69-1.79). Among cases with incident diabetes, the proportion of immigrants (median age, 49 vs. 65 in Italy-born individuals) increased progressively from 11.7% to 26.5% from 2011 to 2019 (males, 8.9-21.0%; females, 14.9-32.8%) in all age groups, particularly in young adults, but also in older subjects. Metabolic control was lower in immigrants, as was adherence to shared diagnostic and therapeutic protocols, without systematic differences in antidiabetic drug use, but much lower use of drugs for comorbid conditions.

Conclusions: The population with diabetes in the metropolitan area of Bologna is rapidly changing. Quality improvement initiatives are needed to reduce the burden for the universalistic Italian health care system generated by the rapidly-growing high-risk immigrant population.

Keywords: Diabetes risk; Drug treatment; Incident diabetes; Metabolic control; Migrants; Protocol adherence.

MeSH terms

  • Aged
  • Diabetes Mellitus* / diagnosis
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Young Adult

Substances

  • Hypoglycemic Agents